Duration of antidepressant use during pregnancy and risk of major congenital malformations

This publication has 31 references indexed in Scilit:

• Use of Selective Serotonin-Reuptake Inhibitors in Pregnancy and the Risk of Birth Defects
  New England Journal of Medicine, 2007
• First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage
  Birth Defects Research Part B: Developmental and Reproductive Toxicology, 2006
• Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn
  New England Journal of Medicine, 2006
• The Safety of Newer Antidepressants in Pregnancy and Breastfeeding
  Drug Safety, 2005
• Eating disorders: recognition, evaluation, and implications for obstetrician/gynecologists
  Primary Care Update for OB/GYNS, 2001
• Improvement of drug exposure data in a registration of congenital anomalies. Pilot-study: Pharmacist and mother as sources for drug exposure data during pregnancy
  Teratology, 1999
• Birth Outcomes in Pregnant Women Taking Fluoxetine
  New England Journal of Medicine, 1996
• Maternal Depressive Symptoms and the Risk of Poor Pregnancy Outcome
  Epidemiologic Reviews, 1995
• Better news on population
  The Lancet, 1992
• Depressive symptoms during pregnancy: Relationship to poor health behaviors
  American Journal of Obstetrics and Gynecology, 1989